VEANA THERAPEUTICS, INC is a privately held Oregon-based biotechnology company whose business strategy is to identify Alpha-TEA (vitamin E analog) cancer immunotherapy technologies. Established in 2012, it is based on the work of its founder, Dr. Emmanuel Akporiaye.
Alpha-TEA immunotherapy technologies are based on orally bioavailable anti-cancer agents that simultaneously kill tumor cells and stimulate the immune system. Alpha TEA’s can be combined with other forms of immunotherapy to further improve their anti-tumor activity.